Skip to main content
. 2011 Feb 23;21(5):533–543. doi: 10.1111/j.1750-3639.2011.00476.x

Table 1.

Pathological and genetic data from patients with PRL pituitary tumors. Abbreviations: A = aggressive PRL tumors; NA = nonaggressive PRL tumors; PRL = prolactin.

Tumor number Sex Age Tumor size (mm3) Invasion Pathological group Postoperative events Chromosome gains Chromosome losses
 1 M 66 4620 Yes A Recurrence, death 3p, 5, 8, 14q, 19p 11p
 2 F 54 4000 Yes A Recurrence 4q 1p, 11p
 3 M 68 5000 Yes A carcinoma Recurrences, metastasis, death 1q, 3p, 8q, 9, 14q, 19p 1q, 11
 4 M 54 6912 Yes A carcinoma Recurrences, metastasis, death 1q, 5, 15q, 19q 11, 17p
 5 F 31 864 Yes A carcinoma Recurrences, metastasis 1q, 8q 1, 4, 11, 13q, 15q
 6 F 43 4600 Yes A Recurrence
 7 M 40 8000 Yes NA Persistence Y
 8 M 41 500 Yes NA Persistence 15q, 2p
 9 M 41 2450 No NA Remission 7, 9
10 F 44 365 No NA Remission 3, 5p, 7, 9 15q
11 M 39 13282 No NA Remission 8, Y
12 F 30 216 No NA Remission 9
13 F 38 1000 No NA Remission 7p, 20 13q